The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|1|76-110

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.1, 2016-01, pp. : 76-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCL2-CCR2 Signaling in Disease Pathogenesis

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 105-118

Bentham Science Publishers

Access to resources Recommend Favorite

CCR5 as Target for HIV-1 Gene Therapy

By  

Current Gene Therapy, Vol. 8, Iss. 4, 2008-08 ,pp. : 264-272

Bentham Science Publishers

Access to resources Recommend Favorite

CCR1 and CCR2 Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 13, 2014-07 ,pp. : 1539-1552

Bentham Science Publishers

Access to resources Recommend Favorite

The CCR2 receptor as a therapeutic target

By Feria Manuel   Díaz-González Federico  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 1, 2006-01 ,pp. : 49-57

Informa Healthcare

Access to resources Recommend Favorite

MCP-1/CCL2 as a Therapeutic Target in Myocardial Infarction and Ischemic Cardiomyopathy

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 2, 2007-06 ,pp. : 101-107

Bentham Science Publishers

Access to resources Recommend Favorite